Marc Alcser

Marc G. Alcser

Marc provides general corporate representation with emphasis on corporate and securities law, mergers and acquisitions, public and private securities offerings, secured and unsecured debt financings, recapitalizations, joint ventures, private equity, and venture capital investments.

His expertise also includes regulation under the SEC and stock exchange compliance (NYSE, NYSE MKT, Nasdaq, Financial Industry Regulatory Authority).

Marc has also advised clients on commercial agreements and other strategic arrangements, such as:

  • Manufacturing
  • Distribution
  • Purchase and supply
  • Service
  • Licensing
  • Development
  • Technology transfer

In addition, he regularly counsels clients on a variety of matters, including compliance, compensation, intellectual property, corporate governance, defensive measures and public disclosures.

Marc's clients have included publicly traded and privately held companies in a variety of industries, including:

He represents acquirers, targets, boards of directors, special committees, and investors in many complex public and private transactions.

Recent Speaking Engagements

  • “M&A: Lessons Learned from the Craft Beer Phenomenon”, ACG's SoCal Capital Summit (November 2017)

  • "A Conversation Regarding M&A Trends and Strategies", Craft Beer Finance and Investment Conference (October 2017)

Experience

Represented VolitionRx in its closing of a confidentially-marked underwritten public offering of common stock, resulting in gross proceeds of $16.5 million, including the subsequent exercise of the overallotment option in full, before deducting underwriting commission and other offering expenses payable by VolitionRx. Prime Executions, Inc. dba Freedom Capital Markets acted as the book-running manager of the offering, and Bancroft Capital, LLC acted as co-manager. 
Stradling client VolitionRx Limited announced the closing of a confidentially-marked underwritten public offering of common stock. The gross proceeds to Volition from the offering, before deducting underwriting commissions and other offering expenses payable by Volition, were approximately $8.7 million. Newbridge Securities Corporation acted as the sole book-running manager of the offering.
Represented VolitionRx in a confidentially-marked underwritten public offering of common stock, including the exercise in full of the overallotment option, resulting in gross proceeds of $6.9 Million. Newbridge Securities Corporation acted as the sole book-running manager of the offer.
View More

Credentials

Education
  • University of California, Davis, J.D., 1996
  • University of Southern California, B.S., business/finance, 1991
  • American Bar Association (Business and Intellectual Property sections)
  • Orange County Bar Association
  • Association for Corporate Growth, Orange County (board member)
  • OCTANe
  • Vista Verde Foundation (board member)
  • California

Related Practices

Related Industries & Initiatives

View All